Use of beta-2 agonists and risk of hip fracture
Main Authors: | De Vries, F, Pouwels, S, Cooper, C, Leufkens, H, Bracke, M, Lammers, J, Van Staa, T |
---|---|
Format: | Journal article |
Published: |
2006
|
Similar Items
-
Use of beta-2 agonists and risk of hip/femur fracture: a population-based case-control study.
by: de Vries, F, et al.
Published: (2007) -
Use of inhaled and oral glucocorticoids, severity of inflammatory disease and risk of hip/femur fracture: a population-based case-control study.
by: de Vries, F, et al.
Published: (2007) -
Use of beta-blockers and the risk of hip/femur fracture in the United Kingdom and The Netherlands.
by: de Vries, F, et al.
Published: (2007) -
Use of beta-blockers and risk of hip and vertebral fracture: relationships to daily and cumulative dose
by: De Vries, F, et al.
Published: (2006) -
Use of protonpump inhibitors and risk of hip fracture
by: Lalmohamed, A, et al.
Published: (2009)